Skip to main content
Skip to footer




According to an industry report, pharmaceutical organizations see a 40% decline in adherence rate within a year of trial commencement. How can they tackle it? How has the COVID-19 pandemic impacted the already complex medication flows? What constitutes the next-generation medication management, and how can organizations enable it?

Our article focuses on next-generation medication management with insights on smart technologies and synergistic partnerships, backed by real-life implementation use cases. Emphasizing on personalized patient support, integrated medication ecosystem, and flexible medication processes, the article envisions the next-generation of medication management that will be fuelled by innovative technologies and symbiotic partnerships, and help us realize preventive, augmented, and embedded smart medication management.  


Dr. Hilde Vanaken

Head, Industry Leaders, TCS Life Sciences and Healthcare